327 related articles for article (PubMed ID: 12808147)
1. Membrane-binding and activation mechanism of PTEN.
Das S; Dixon JE; Cho W
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7491-6. PubMed ID: 12808147
[TBL] [Abstract][Full Text] [Related]
2. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.
Georgescu MM; Kirsch KH; Kaloudis P; Yang H; Pavletich NP; Hanafusa H
Cancer Res; 2000 Dec; 60(24):7033-8. PubMed ID: 11156408
[TBL] [Abstract][Full Text] [Related]
3. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.
Valiente M; Andrés-Pons A; Gomar B; Torres J; Gil A; Tapparel C; Antonarakis SE; Pulido R
J Biol Chem; 2005 Aug; 280(32):28936-43. PubMed ID: 15951562
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex.
Vazquez F; Grossman SR; Takahashi Y; Rokas MV; Nakamura N; Sellers WR
J Biol Chem; 2001 Dec; 276(52):48627-30. PubMed ID: 11707428
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase.
Mahimainathan L; Choudhury GG
J Biol Chem; 2004 Apr; 279(15):15258-68. PubMed ID: 14718524
[TBL] [Abstract][Full Text] [Related]
6. Acute regulation of the tumour suppressor phosphatase, PTEN, by anionic lipids and reactive oxygen species.
Downes CP; Walker S; McConnachie G; Lindsay Y; Batty IH; Leslie NR
Biochem Soc Trans; 2004 Apr; 32(Pt 2):338-42. PubMed ID: 15046604
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
[TBL] [Abstract][Full Text] [Related]
8. PTEN does not modulate GLUT4 translocation in rat adipose cells under physiological conditions.
Mosser VA; Li Y; Quon MJ
Biochem Biophys Res Commun; 2001 Nov; 288(4):1011-7. PubMed ID: 11689011
[TBL] [Abstract][Full Text] [Related]
9. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
[TBL] [Abstract][Full Text] [Related]
11. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the PTEN tail regulates protein stability and function.
Vazquez F; Ramaswamy S; Nakamura N; Sellers WR
Mol Cell Biol; 2000 Jul; 20(14):5010-8. PubMed ID: 10866658
[TBL] [Abstract][Full Text] [Related]
13. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.
Maier D; Jones G; Li X; Schönthal AH; Gratzl O; Van Meir EG; Merlo A
Cancer Res; 1999 Nov; 59(21):5479-82. PubMed ID: 10554022
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.
Lee JO; Yang H; Georgescu MM; Di Cristofano A; Maehama T; Shi Y; Dixon JE; Pandolfi P; Pavletich NP
Cell; 1999 Oct; 99(3):323-34. PubMed ID: 10555148
[TBL] [Abstract][Full Text] [Related]
15. Functional definition of relevant epitopes on the tumor suppressor PTEN protein.
Andrés-Pons A; Valiente M; Torres J; Gil A; Roglá I; Ripoll F; Cervera J; Pulido R
Cancer Lett; 2005 Jun; 223(2):303-12. PubMed ID: 15896465
[TBL] [Abstract][Full Text] [Related]
16. Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines.
Goswami R; Singh D; Phillips G; Kilkus J; Dawson G
J Neurosci Res; 2005 Aug; 81(4):541-50. PubMed ID: 15968641
[TBL] [Abstract][Full Text] [Related]
17. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
Wu X; Hepner K; Castelino-Prabhu S; Do D; Kaye MB; Yuan XJ; Wood J; Ross C; Sawyers CL; Whang YE
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4233-8. PubMed ID: 10760291
[TBL] [Abstract][Full Text] [Related]
18. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor.
Sanchez T; Thangada S; Wu MT; Kontos CD; Wu D; Wu H; Hla T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4312-7. PubMed ID: 15764699
[TBL] [Abstract][Full Text] [Related]
19. Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.
Adey NB; Huang L; Ormonde PA; Baumgard ML; Pero R; Byreddy DV; Tavtigian SV; Bartel PL
Cancer Res; 2000 Jan; 60(1):35-7. PubMed ID: 10646847
[TBL] [Abstract][Full Text] [Related]
20. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt.
Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL
Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
